Sorted By:

Relevance


Biologics Research Promises to Bolster Future of Medicine

PhRMA  |  Press Release

(March 11, 2013) – America’s biopharmaceutical companies are using biological processes to develop 907 medicines and vaccines targeting more than 100 diseases, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).
https://www.phrma.org/press-release/biologics-research-promises-to-bolster-future-of-medicine

PhRMA Statement on Senator Warren’s Proposal

PhRMA  |  Press Release

(January 22, 2015) — Pharmaceutical Research and Manufacturers of America (PhRMA) senior vice president, communications, Robert Zirkelbach released the following statement: “Developing innovative, lifesaving medicines for patients is the sole focus of the biopharmaceutical industry.
https://www.phrma.org/press-release/phrma-statement-on-senator-warren-s-proposal

PhRMA Statement on Preserving American Jobs, Fostering Innovation

PhRMA  |  Press Release

Castellani released the following statement today about American jobs:   “We look forward to hearing the President’s vision for the economy and job growth in America.
https://www.phrma.org/press-release/phrma-statement-on-preserving-american-jobs-fostering-innovation

Robust Biopharmaceutical Pipeline Offers New Hope for Patients

PhRMA  |  Press Release

(January 17, 2013) —The biopharmaceutical pipeline is innovative and robust, with a high proportion of potential first-in-class medicines and therapies targeting diseases with limited treatment options, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).  
https://www.phrma.org/press-release/robust-biopharmaceutical-pipeline-offers-new-hope-for-patients

PhRMA Statement on Patent Settlements

PhRMA  |  Press Release

Washington, D.C. (January 13, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) Executive Vice President and General Counsel Diane Bieri issued the following statement today about a Federal Trade Commission report on settlements between brand-name and generics ...
https://www.phrma.org/press-release/phrma-statement-on-patent-settlements

PhRMA Statement Regarding FDA Approvals

PhRMA  |  Press Release

Washington, D.C. (November 3, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President for Scientific and Regulatory Affairs Dr. David E. Wheadon issued the following statement today on FDA’s report, FY 2011 Innovative Drug Approvals:  ...
https://www.phrma.org/press-release/phrma-statement-regarding-fda-approvals

PhRMA Statement on SCOTUS Ruling

PhRMA  |  Press Release

Washington, D.C. (June 28, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani issued the following statement today: “We respect the Court’s decision and recognize that there will be ongoing policy discussions about the...
https://www.phrma.org/press-release/phrma-statement-on-scotus-ruling

PhRMA Launches AccessBetterCoverage.org

PhRMA  |  Press Release

Washington, D.C. (October 14, 2014) — Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) launched Access Better Coverage.org, a new website designed to educate consumers about the ABCs of health coverage and ...
https://www.phrma.org/press-release/phrma-launches-accessbettercoverage-org

PhRMA Statement on the Trans-Pacific Partnership Negotiations

PhRMA  |  Press Release

Connect with PhRMAFor information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA  
https://www.phrma.org/press-release/phrma-statement-on-the-trans-pacific-partnership-negotiations

Castellani Statement on Prescription Drug Costs

PhRMA  |  Press Release

FACT: Many patients with Exchange coverage are required to pay more than twice as much out of pocket for prescription medicines than they would under a typical employer plan.
https://www.phrma.org/press-release/castellani-statement-on-prescription-drug-costs

PhRMA Statement on Clinical Trials and Bad Pharma

PhRMA  |  Press Release

 “Following FDA approval of a medicine, the FDA releases a comprehensive summary approval package, which includes analysis of all significant clinical trials used for the approval process.
https://www.phrma.org/press-release/phrma-statement-on-clinical-trials-and-bad-pharma

PhRMA Statement on Prescription Drug Importation

PhRMA  |  Press Release

For more information about the worldwide counterfeit threat, go to www.buysafedrugs.info.
https://www.phrma.org/press-release/phrma-statement-on-prescription-drug-importation

PhRMA Statement on Peer Education Programs

PhRMA  |  Press Release

Washington, D.C. (October 21, 2010) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani [bio] today issued the following statement on peer education programs conduct...
https://www.phrma.org/press-release/phrma-statement-on-peer-education-programs

PhRMA Statement on Burden of Cancer

PhRMA  |  Press Release

Washington, D.C. (August 19, 2010) — The Pharmaceutical Research and Manufacturers of America (PhRMA) issued the following statement today regarding the American Cancer Society...
https://www.phrma.org/press-release/phrma-statement-on-burden-of-cancer

Statement to State of the Union Address

PhRMA  |  Press Release

WASHINGTON, D.C. (February 13, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today: “The President has again proposed to upend the successful Medicare Part D prescription drug progr...
https://www.phrma.org/press-release/statement-to-state-of-the-union-address

PhRMA Statement on Expansion of SCHIP

PhRMA  |  Press Release

Washington, D.C. (February 4, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today regarding the State Children’s Health Insurance Program Reauthorization Act: “President Obama’s signing in...
https://www.phrma.org/press-release/phrma-statement-on-expansion-of-schip

PhRMA Statement on Human Brain Mapping Initiative

PhRMA  |  Press Release

WASHINGTON, D.C. (February 18, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today regarding a new initiative by the Administration that could help further medical research for neurologica...
https://www.phrma.org/press-release/phrma-statement-on-human-brain-mapping-initiative

PhRMA Statement Supporting House Vote on Biosimilars

PhRMA  |  Press Release

Washington, D.C. (July 31, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today regarding the U.S. House Committee on Energy & Commerce’s endorsement of reasonable data protection: “PhR...
https://www.phrma.org/press-release/phrma-statement-supporting-house-vote-on-biosimilars

PhRMA Establishes New Committee on Small Biopharmaceutical Companies

PhRMA  |  Press Release

Washington, D.C. (July 8, 2009) — The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced the creation of a new committee of its Board of Directors dedicated to small biopharmaceutical companies. PhRMA’s Board of Directors recently approved the est...
https://www.phrma.org/press-release/phrma-establishes-new-committee-on-small-biopharmaceutical-companies

PhRMA Statement on HELP Committee Health Reform Vote

PhRMA  |  Press Release

Washington, D.C. (July 15, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement regarding the Senate Health, Education, Labor and Pensions Committee’s vote in favor of the “Quality, Affordable Health Co...
https://www.phrma.org/press-release/phrma-statement-on-help-committee-health-reform-vote

PhRMA Statement on Interactions with Healthcare Professionals

PhRMA  |  Press Release

Washington, D.C. (September 6, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) Executive Vice President and General Counsel Diane Bieri today issued the following statement on interactions with healthcare professionals: “Interactions between biopharmac...
https://www.phrma.org/press-release/phrma-statement-on-interactions-with-healthcare-professionals

Statement Regarding GAO Report on Drug Prices

PhRMA  |  Press Release

Washington, D.C. (March 14, 2011) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani issued the following statement regarding the Government Accountability Office’s (GAO) report on drug prices: “We are pleased the GAO approp...
https://www.phrma.org/press-release/statement-regarding-gao-report-on-drug-prices

PhRMA Elects New Member to Board of Directors

PhRMA  |  Press Release

Washington, D.C. (April 22, 2013) — The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today the election of Orexigen Therapeutics President and CEO Michael A. Narachi to its Board of Directors. “I am...
https://www.phrma.org/press-release/phrma-elects-new-member-to-board-of-directors

PhRMA Statement on Prescription Drug Costs

PhRMA  |  Press Release

“GPhA’s release offers important information about why we need to maintain incentives that support the development of new medicines.
https://www.phrma.org/press-release/phrma-statement-on-prescription-drug-costs

Use of SI Units in Regulatory Submission

PhRMA  |  Press Release

PhRMA supports the FDA’s consideration of SI units as the standard for regulatory submissions and looks forward to working with the Agency on establishing clear recommendations for the use of SI units through the release of draft guidance for industry on this issue for public comment. 
https://www.phrma.org/press-release/use-of-si-units-in-regulatory-submission

You have reviewed the first 125 results out of 879. Each page contains 25 results. You're on page 5.

prev 1 2 3 4 5 6 next